pISSN 2508-6235 eISSN 2508-7576

Table. 2.

The effects of AMP on categorys (random-effects model)

Category?SubgroupK?Hedges’g?95% CII2 (%)P

?Lower limit??Upper limit?
Anthropometric index?BW?43?0.130.090.180?0.997?
BMI310.120.080.1700.999
Body fat (%)500.310.220.3971.3<0.001
LBM210.150.070.2400.999
WC210.230.140.3140.90.027
WHR220.120.060.1800.878
Fat-distributionTAF120.460.180.7577.1<0.001
AVAT200.420.220.6175.7<0.001
ASAT200.190.110.2800.988
V/S130.480.220.7374.6<0.001
Metabolim indexHDL270.190.110.2628.80.082
LDL180.250.150.35260.150
Total Cholesterol260.210.140.2935.70.038
Tiglyceride270.140.090.1900.944
Apolipoprotein A-I?60.270.070.4700.591
Apolipoprotein B60.220.020.4200.444
Glucose180.250.120.3764.9<0.001
Homocystein20.300.050.5469.70.069
Insulin110.150.070.2400.787
Atherogenic index30.550.250.8400.999
HOMA-IR90.370.230.5100.883
FFA40.32-0.010.6671.40.015
Inflammatory indexTNF-α41.190.362.0291.8<0.001
CRP40.12-0.040.2941.10.165
Adiponectin60.250.080.4127.60.228
Resistin40.18-0.030.3900.937

AMP, abdominal management program; K, number of studies; BW, body weight; BMI, body mass index; LBM, lean body mass; WC, waist circumference; WHR, waist-hip ratio; TAF, total abdominal fat; AVAT, abdominal visceral adipose tissue; ASAT, abdominal subcutaneous adipose tissue; V/S, ratio of visceral and subcutaneous fat; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; HOMA IR, homeostatic model assessment insulin resistance; FFA, free fatty acid; TNF-α, tumor necrosis factor α; CRP, C-reactive protein.

Korean J Obes 2016;25:138~149 https://doi.org/10.7570/kjo.2016.25.3.138
© JOMES